Showing results (1821-1830 of 2,429) with videos related to

Sort By:
Pageof 243
The New England Journal of Medicine|April 21, 2006
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndromeKenneth P Steinberg, Leonard D Hudson, Richard B Goodman, et al.
Environmental Health Perspectives|November 1, 1992
The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancerB Ketterer, J M Harris, G Talaska, et al.
The Journal of Knee Surgery|January 19, 2023
Clinical Outcomes after Computed Tomography-Based Total Knee Arthroplasty: A Minimum 3-Year AnalysesRobert C Marchand, Laura Scholl, Kelly B Taylor, et al.
Journal of Athletic Training|January 13, 2023
Sex-Specific Changes in Physical Risk Factors for Anterior Cruciate Ligament Injury by Chronological Age and Stages of Growth and Maturation From 8 to 18 Years of AgeSandra J Shultz, Marcelo Rodriguez Cruz, Ellen Casey, et al.
Nucleic Acids Research|January 23, 2008
The crystal structure of Nep1 reveals an extended SPOUT-class methyltransferase fold and a pre-organized SAM-binding siteAlexander B Taylor, Britta Meyer, Belinda Z Leal, et al.
Clinical and Translational Radiation Oncology|March 22, 2021
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancerK Haslett, P Koh, A Hudson, et al.
Microbial Cell (Graz, Austria)|March 31, 2017
Evolutionary rewiring of bacterial regulatory networksTiffany B Taylor, Geraldine Mulley, Liam J McGuffin, et al.
Journal of Animal Science|June 26, 2004
Effect of high-selenium wheat on visceral organ mass, and intestinal cellularity and vascularity in finishing beef steersS A Soto-Navarro, T L Lawler, J B Taylor, et al.
American Journal of Nephrology|September 24, 2005
Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndromeFrederic Clayton, Theodore J Pysher, Randall Lou, et al.
Molecular & Cellular Proteomics : MCP|June 19, 2021
MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future ImmunotherapiesHannah B Taylor, Susan Klaeger, Karl R Clauser, et al.
Pageof 243